Raynaud phenomenon: from GWAS to drug repurposing

Nature Reviews Rheumatology, Published online: 16 January 2024; doi:10.1038/s41584-024-01076-xThe identification of novel risk variants in the largest genome-wide association study of Raynaud phenomenon to date provides insights into the pathophysiology of the condition, including the potential role for α2A-adrenoceptors, and suggests opportunities for drug repurposing.
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Source Type: research